Stockreport

I-Mab Filed 2019 Annual Report on Form 20-F

I-MAB - American Depositary Shares  (IMAB) 
PDF SHANGHAI, China and ROCKVILLE, MD., April 29, 2020 (GLOBE NEWSWIRE) -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to th [Read more]